Results 11 to 20 of about 1,168 (140)

Derivation of a health-based guidance value for Δ⁸-tetrahydrocannabinol (Δ⁸-THC) and its occurrence in food. [PDF]

EFSA J
Abstract The European Food Safety Authority (EFSA) was asked to deliver a scientific opinion on the derivation of a health‐based guidance value (HBGV) for Δ8‐tetrahydrocannabinol (Δ8‐THC) in food with an assessment of the occurrence of Δ8‐THC and the co‐occurrence with Δ9‐THC in hemp and hemp‐derived products.
EFSA Panel on Contaminants in the Food Chain (CONTAM), Knutsen HK, Åkesson A, Bampidis V, Bignami M, Chipman JK, Degen G, Hernández-Jerez A, Hofer T, Hogstrand C, Landi S, Leblanc JC, Machera K, Ntzani E, Oswald IP, Rychen G, Sand S, Vejdovszky K, Viviani B, Dusemund B, Nebbia C, Weigel S, Cascio C, Christodoulidou A, Abrahantes JC, Dujardin B, Gissi A, Asensio LA, Gkimprixi E, Tauriainen T, Bodin L.   +30 more
europepmc   +2 more sources

Higher viral load and infectivity increase risk of aerosol transmission for Delta and Omicron variants of SARS-CoV-2. [PDF]

, 2022
Airborne transmission of SARS-CoV-2 is an important route of infection. For the wildtype (WT) only a small proportion of those infected emitted large quantities of the virus.
Albani, D., Briceno-Ayala, L., Ichihara, G., Iff, S., Monn, C., Poffet, D., Riediker, M., Tsai, D.H.   +7 more
core   +1 more source

Prospective evaluation of the tolerability and efficacy of niraparib dosing based on baseline body weight and platelet count: Results from the PRIMA/ENGOT‐OV26/GOG‐3012 trial

Cancer, Volume 129, Issue 12, Page 1846-1855, 15 June 2023., 2023
Abstract Background The PRIMA/ENGOT‐OV26/GOG‐3012 (NCT02655016) trial was amended to prospectively evaluate the safety and efficacy of an individualized starting dose (ISD) regimen of niraparib for first‐line maintenance therapy in patients with newly diagnosed advanced ovarian cancer.
Mansoor R. Mirza, Antonio González‐Martín, Whitney S. Graybill, David M. O’Malley, Lydia Gaba, Oi Wah Stephanie Yap, Eva M. Guerra, Peter G. Rose, Jean‐François Baurain, Sharad A. Ghamande, Hannelore Denys, Emily Prendergast, Carmela Pisano, Philippe Follana, Klaus Baumann, Paula M. Calvert, Jacob Korach, Yong Li, Izabela A. Malinowska, Divya Gupta, Bradley J. Monk   +20 more
wiley   +1 more source

The clinical features, management and outcomes of lymphoma in pregnancy: A multicentre study by the Australasian Lymphoma Alliance

British Journal of Haematology, Volume 201, Issue 5, Page 887-896, June 2023., 2023
Summary Lymphoma in pregnancy (LIP) presents unique clinical, social and ethical challenges; however, the evidence regarding this clinical scenario is limited. We conducted a multicentre retrospective observational study reporting on the features, management, and outcomes of LIP in patients diagnosed between January 2009 and December 2020 at 16 sites ...
Pietro R. Di Ciaccio, Georgia Mills, Michael J. Shipton, Belinda Campbell, Gareth Gregory, Jenna Langfield, Matthew Greenwood, Sean McKeague, Mohammad Shanavas, Renee Eslick, Giselle Kidson‐Gerber, Portia Smallbone, Catherine Tang, Kirk Morris, Ian Bilmon, Costas K. Yannakou, Xavier Badoux, Leanne Berkahn, Sergio Farina, Kylie D. Mason, Penelope Motum, Kathryn Goss, Nada Hamad   +22 more
wiley   +1 more source

Matching‐adjusted indirect comparison of isatuximab plus carfilzomib and dexamethasone with daratumumab plus lenalidomide and dexamethasone in relapsed multiple myeloma

Cancer Medicine, Volume 12, Issue 7, Page 8005-8017, April 2023., 2023
Matching‐adjusted indirect comparison results for Isa‐Kd vs. Dara‐Rd: Kaplan‐Meier curves of progression‐free survival before matching and after inclusion criteria selection (A) and after matching (B); Kaplan‐Meier curves of overall survival before matching and after inclusion criteria selection (C) and after matching (D). CI, confidence interval; Dara‐
Joshua Richter, Peggy L. Lin, Viviana Garcia‐Horton, Patricia Guyot, Erin Singh, Zheng‐Yi Zhou, Mark Sievert, Riley Taiji   +7 more
wiley   +1 more source

Prognostic impact of MYD88 and CXCR4 mutations assessed by droplet digital polymerase chain reaction in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenström macroglobulinaemia

British Journal of Haematology, Volume 200, Issue 2, Page 187-196, January 2023., 2023
Summary Waldenström macroglobulinaemia (WM) is characterized by recurrent somatic mutations in MYD88 and CXCR4 genes. However, limitations arise when analysing these mutations in IgM monoclonal gammopathy of undetermined significance (MGUS) or smouldering WM (SWM) given the lower tumour load.
David F. Moreno, Mónica López‐Guerra, Sara Paz, Aina Oliver‐Caldés, Mari‐Pau Mena, Juan G. Correa, Anthony M. Battram, Miguel Osuna, Alfredo Rivas‐Delgado, Luis Gerardo Rodríguez‐Lobato, Oriol Cardús, Natalia Tovar, María Teresa Cibeira, Raquel Jiménez‐Segura, Joan Bladé, Laura Rosiñol, Dolors Colomer, Carlos Fernández de Larrea   +17 more
wiley   +1 more source

Turning the tide? Economic reforms and union revival in India

Industrial Relations Journal, Volume 52, Issue 4, Page 364-385, July 2021., 2021
Abstract Despite nearly three decades of ostensibly pro‐employer economic reforms in India, trade union membership and density in India appear to have risen. Although similar trends have been reported and investigated in other emerging economies such as China and South Africa, the union revival thesis in India is yet to be fully explored.
Vidu Badigannavar, John Kelly, Manik Kumar   +2 more
wiley   +1 more source

Direct Digital Sensing Potentiostat targeting Body-Dust [PDF]

, 2022
In this paper, an innovative Direct Digital Sensing Potentiostat integrated circuit for enzymeless blood glucose sensing and direct digitization is proposed to address the requirements of Body Dust. The circuit occupies a silicon area of 460 μm2 in 180nm
Paolo Crovetti, Roberto Rubino, Sandro Carrara   +2 more
core   +1 more source

Systematic review and network meta-analysis on the efficacy of evolocumab and other therapies for the management of lipid levels in hyperlipidemia [PDF]

, 2017
Background: The proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors evolocumab and alirocumab substantially reduce low‐density lipoprotein cholesterol (LDL‐C) when added to statin therapy in patients who need additional LDL‐C reduction ...
Bray, Sarah, Bridges, Ian, Cheng, Lung-I, Dent, Ricardo, Deshpande, Sohan, Forbes, Carol A., Gandra, Shravanthi R., Kleijnen, Jos, Ross, Janine, Sattar, Naveed, Stroes, Erik S.G., Toth, Peter P., Worth, Gavin M., Worthy, Gillian   +13 more
core   +1 more source

The Creation of a Biophysical Modeling Universe: The UNIfied and VERSatile bio response Engine [PDF]

, 2023
Radiotherapy is a crucial pillar of cancer therapy and ion beams promise superior dose conformity and potentially enhanced biological effectiveness in comparison to conventional radiation modalities.
Liew, Hans
core   +1 more source